Table 2.
Characteristics of deceased and living patients diagnosed with COVID-19.
| Demographics and risk factors | Deceased patients with COVID-19 (n=855) | Living patients with COVID-19 (n=22,989) | Adjusted odds ratio (95% CI) | P valuea | ||||||||
| Demographics | ||||||||||||
|
|
Age (years), mean (SD) | 83 (10.8) | 48.7 (19.2) | 1.12 (1.11-1.13) | <.001 | |||||||
|
|
Sex | 2.22 (1.90-2.60) | <.001 | |||||||||
|
|
|
Male |
468 (54.7) | 13,295 (57.8) |
|
|
||||||
|
|
|
Female | 387 (45.3) | 9694 (42.2) |
|
|
||||||
| Risk factors | ||||||||||||
|
|
Hypertension | 587 (68.7) | 4680 (20.4) | 1.16 (0.98-1.37) | .09 | |||||||
|
|
Diabetes | 278 (32.5) | 1823 (7.9) | 1.69 (1.43-1.99) | <.001 | |||||||
|
|
Dyslipidemia | 383 (44.7) | 4367 (19.0) | 1.19 (1.03-1.39) | .03 | |||||||
|
|
Obesity | 250 (29.2) | 4931 (21.5) | 1.08 (0.91-1.27) | .38 | |||||||
|
|
Chronic obstructive pulmonary disease |
105 (12.3) |
580 (2.5) |
1.18 (0.92-1.51) |
.19 |
|||||||
|
|
Cancer | 210 (24.6) | 1555 (6.8) | 1.19 (0.99-1.43) | .06 | |||||||
|
|
Current smoker | 37 (4.3) | 3541 (15.4) | 0.98 (0.67-1.39) | .93 | |||||||
|
|
Heart failure | 127 (14.9) | 388 (1.7) | 1.59 (1.26-1.99) | <.001 | |||||||
|
|
Cerebrovascular disease | 21 (2.5) | 155 (0.7) | 0.84 (0.50-1.33) | .47 | |||||||
|
|
Ischemic heart disease | 93 (10.9) | 534 (2.3) | 1.20 (0.93-1.54) | .15 | |||||||
|
|
Treatment with ACEIsb | 152 (17.8) | 1549 (6.7) | 0.90 (0.74-1.09) | .32 | |||||||
|
|
Treatment with ARBsc | 75 (8.8) | 654 (2.8) | 1.00 (0.76-1.30) | .98 | |||||||
aIn the multivariate analysis, sex was adjusted for age and age was adjusted for sex. The remaining risk factors were adjusted for age and sex.
bACEIs: angiotensin-converting-enzyme inhibitors.
cARBs: angiotensin II receptor blockers.